Delivery Order 75N93024D00004-75N93026F00001
Award Date 7/1/26
Potential Completion Date 6/30/27
Potential Value $4.3M
Federal Agency
Ultimate Awardee
Not listed Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Cost Plus Fixed Fee
Place of Performance
Manassas, VA 20110, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- <p>The National Institute of Allergy and Infectious Diseases issued a delivery order to American Type Culture Collection on January 11, 2019, with a ceiling value of $2,500 under the In Vitro Assessments of Antimicrobial Activity (IVAAA) IDIQ for in vitro assessments of antimicrobial activity.</p> <p>Place of performance is Manassas, VA 20110. The order is firm fixed price with an ultimate completion date of September 30, 2020. No set-aside was used.</p>
- <p>The National Institute of Allergy and Infectious Diseases issued a $2,500 delivery order to American Type Culture Collection on January 11, 2019, under the In Vitro Assessments of Antimicrobial Activity (IVAAA) parent contract for in vitro assessments of antimicrobial activity.</p> <p>Place of performance is Manassas, Virginia. The order has a firm fixed price structure with an ultimate completion date of September 30, 2020. No set-aside was used.</p>
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a delivery order valued at $3.27 million to American Type Culture Collection (ATCC) on January 17, 2022, for the production of well-characterized challenge material of Biosafety Level 3 and 4 viruses. ATCC, a nonprofit biological resource center based in Manassas, Virginia, specializes in collecting, authenticating, and distributing microorganisms and biological materials critical to infectious disease research and medical...
- The National Institute of Allergy and Infectious Diseases issued a delivery order to Pharmacology Discovery Services Taiwan, LTD. on August 3, 2018, under the NIAID Preclinical Models of Infectious Diseases 2017-2024 IDIQ, with a ceiling value of $1,272,675 to exercise options 1, 2, and 5 for therapeutic testing in murine models of bacterial thigh and lung infections as preclinical models of infectious diseases. Place of performance is St Charles, MO. The order is firm fixed price with an...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $333.7 million definitive contract to American Type Culture Collection (ATCC) on October 16, 2023, for the continuation of the Biological and Emerging Infections Research Resources Program (BEI-RRP). This cost-plus-fixed-fee contract, with an ultimate completion date of October 15, 2030, establishes ATCC as the central repository operator for quality-assured organisms, reagents, tools, services, and information...
- The National Institute of Allergy and Infectious Diseases issued a delivery order to Pharmacology Discovery Services Taiwan, LTD. on September 6, 2018, with a ceiling value of $1,797,620 under the NIAID Preclinical Models of Infectious Diseases 2017-2024 IDIQ for Task A25, exercising Options A, B, and C to provide preclinical models of infectious diseases. Place of performance is St Charles, MO. The order is firm fixed price with an ultimate completion date of September 14, 2019. The delivery...
- The National Institute of Allergy and Infectious Diseases issued a $6.74 million delivery order to the University of Texas Medical Branch at Galveston on June 25, 2024, under the NIAID Preclinical Models of Infectious Diseases 2017–2024 indefinite delivery vehicle for development of medical countermeasures and animal models for biosafety level 4 agents in non-human primates. The order is priced on a cost, no-fee basis with a ceiling value of $6.74 million and an ultimate completion date of...
- The National Institute of Allergy and Infectious Diseases issued a delivery order to Colorado State University on June 2, 2026, under the Preclinical Models of Infectious Diseases indefinite delivery contract for model development and in vivo screening of antivirals directed against select togaviruses, with a ceiling value of $993,995. The Preclinical Models of Infectious Diseases IDV, valued at $146.3 million with an ordering period through July 14, 2031, supports NIAID's mission to understand,...
- The National Institute of Allergy and Infectious Diseases issued a delivery order to Pharmacology Discovery Services Taiwan, LTD. on August 10, 2021, with a ceiling value of $1.747930 million, under the NIAID Preclinical Models of Infectious Diseases 2017-2024 IDIQ for preclinical models of bacterial infection and therapeutic testing in murine models. The IDIQ supports development and supply of advanced animal models for screening and evaluating medical countermeasures including therapeutics,...
- The National Institute of Allergy and Infectious Diseases issued a delivery order to Advanced Bioscience Laboratories, Inc., on September 6, 2017, with a ceiling value of $110,115.92 under the Preclinical Services for Biopharmaceutical Product Development IDIQ. Place of performance is Rockville, MD. The order was initially set to run through February 10, 2018 and was extended to April 13, 2018 at no additional cost. Pricing is cost plus fixed fee. No set-aside was used for this order.